Georgia House Bill HB101

Georgia 2025-2026 Regular Session

• Introduced: 1/17/25
• Report Pass: 3/6/25

Caption

State employees; annual public report on the amount of prescription drug rebates and other price concessions applied to premium reductions; provide

Impact

The implementation of HB101 will require the state health board to provide detailed disclosures regarding the financial aspects of prescription drug expenditures. By establishing this accountability mechanism, the state can better monitor the efficiency of its health plans and make informed decisions regarding healthcare resources. This is particularly significant for state employees who rely heavily on the consistency and affordability of their health insurance. The annual reports will include metrics on rebates and price concessions, which could encourage the state to negotiate better prices with pharmaceutical companies and vendors.

Summary

House Bill 101 seeks to amend existing state law by mandating an annual public report on the amount of prescription drug rebates and other price concessions that contribute to premium reductions for state health plan participants. This initiative is intended to enhance transparency regarding the financial arrangements and savings achieved within state health plans. Such reports will help state employees understand the direct impact of pharmaceutical pricing strategies on their health benefits and premiums. The legislation aims to build trust and accountability in the management of state healthcare resources.

Contention

While proponents of the bill advocate for greater transparency and accountability in state health expenditure, there may be contention concerning how comprehensive and detailed these reports will be. Critics might argue that simply providing this information may not compel change in pricing practices by manufacturers and could lead to bureaucratic inefficiencies. Additionally, questions regarding the protections of proprietary information or the definitions of rebates and price concessions could arise, potentially complicating the report process and its effectiveness.